|
|
|
|
|
|
|
30.07.26 - 14:03
|
ASP Isotopes to Participate in Canaccord Genuity′s 46th Annual Growth Conference on August 12, 2026 (GlobeNewswire EN)
|
|
|
DALLAS, July 30, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that Viktor Petkov, Chief Commercial Officer, will deliver a company presentation on Wednesday, August 12, 2026, at 8:00 a.m. ET....
|
|
|
28.07.26 - 14:03
|
ASP Isotopes to Hold Capital Markets Day on September 8 (GlobeNewswire EN)
|
|
|
DALLAS, July 28, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that it will hold a Capital Markets Day in London on Tuesday, September 8, 2026, beginning at 10:00 a.m. ET (3:00 p.m. BST)....
|
|
|
21.07.26 - 19:31
|
ASP Isotopes Targets America′s Uranium Conversion Chokepoint (ZeroHedge)
|
|
|
ASP Isotopes Targets America's Uranium Conversion Chokepoint
ASP Isotopes announced Tuesday that its Quantum Leap Energy subsidiary signed a research agreement with the Texas A&M Engineering Experiment Station to advance and de-risk the commercial production of uranium hexafluoride, or UF6.
The work will focus on gathering data on the reactions used to convert uranium concentrate (yellowcake or U3O8) into UF6. The research is intended to support process design, modeling, scale-up, cost reductions, and the eventual commercialization of QLE's conversion technology.
This is the unglamorous but essential middle of the nuclear fuel chain. Uranium miners can produce all the yellowcake they want, but commercial enrichment facilities cannot use it until it has been converted into UF6. The US currently has only one operating commercial conversion facility, ConverDyn's Metropolis Works plant in Illinois, while the World Nuclear Association counted only four conversion suppliers globally as of 2025.
I...
|
|
|
|
|
|
|
|
|
|
|
25.06.26 - 15:54
|
ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing (Business Wire)
|
|
|
Combination, if successful, would establish Noble Africa as a Nasdaq-listed, helium platform for Renergen's Virginia Gas Project
Listing expected to provide investors with direct exposure to one of the few publicly traded helium development assets globally, at a time of tightening supply
Concurrent private placement expected to generate approximately $50 million in gross proceeds to support project developmentDALLAS & ANN ARBOR, Mich.--(BUSINESS WIRE)--$NDRA #MASLD--ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes," “ASPI” or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, and ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or “NDRA”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today announced that ASP Isotopes' wholly-owned subsidiary, Noble Africa LLC (“Noble Africa”), an intermed...
|
|
|
|
|
26.05.26 - 16:06
|
ASP Isotopes Soars On Restart Of Silicon-28 Facility, Locks In Q3 2026 Commercial Shipments (ZeroHedge)
|
|
|
ASP Isotopes Soars On Restart Of Silicon-28 Facility, Locks In Q3 2026 Commercial Shipments
ASP Isotopes cleared a major operational milestone at its Pretoria Silicon-28 enrichment facility, restarting the first 18 stages, and has now run them for over three weeks at target enrichment levels. Commercial shipments to U.S. customers are on track for Q3 2026.
The stock was up over 25% in early trading, back at its highest levels since January...
The restart follows nine months of targeted engineering work on non-core components. Fixes will now roll out across the remaining stages, and samples shipped to a U.S. customer last August already confirmed enrichment performance matched theoretical models.
Three commercial contracts are already signed with American buyers.
“As we scale our production capabilities over the coming quarters, both of these applications will be central to our strategy,” said Stefano Marani, President of ASP Isotopes' Electronics and Space division. “We have seen cons...
|
|
|
|
|
|
|
|
|
11.05.26 - 18:45
|
ASP Isotopes Subsidiary Signs MOU With European Nuclear Technology Company For Fuel Supply (ZeroHedge)
|
|
|
ASP Isotopes Subsidiary Signs MOU With European Nuclear Technology Company For Fuel Supply
ASP Isotopes said its subsidiary Quantum Leap Energy LLC has signed a non-binding memorandum of understanding with an unnamed European nuclear technology company to explore a potential long-term partnership to supply fuel for advanced nuclear reactors, according to a company press release Monday morning.
The agreement focuses on high-assay low-enriched uranium (HALEU), a type of nuclear fuel enriched to more than 10% uranium-235 that is expected to play a key role in powering next-generation reactors. Under the proposed arrangement, the European company would provide uranium feedstock to Quantum Leap Energy's planned conversion and enrichment facilities, where it would be processed into HALEU and potentially deconverted before being delivered back to the partner.
The PR says that the companies said they will conduct technical and economic assessments to determine whether a long-term commercial partne...
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
